Andrew Wong MD, MSc, MBA

Mr. Wong is responsible for corporate strategy and business development for a Walvax subsidiary and is managing collaboration with international organizations for Walvax. He received medical, graduate, and management training in China, Canada, and the USA. Mr. Wong had 11.5 years’ tenure at Amgen by focusing on antibody therapeutics and anticancer drug development.